
- /
- Supported exchanges
- / US
- / DGX.NYSE
Quest Diagnostics Incorporated (DGX NYSE) stock market data APIs
Quest Diagnostics Incorporated Financial Data Overview
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Quest Diagnostics Incorporated data using free add-ons & libraries
Get Quest Diagnostics Incorporated Fundamental Data
Quest Diagnostics Incorporated Fundamental data includes:
- Net Revenue: 10 158 M
- EBITDA: 1 975 M
- Earnings Per Share: 7
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-21
- EPS/Forecast: 2.1502
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Quest Diagnostics Incorporated News

Quest Diagnostics First Quarter 2025 Earnings: EPS Beats Expectations
Quest Diagnostics (NYSE:DGX) First Quarter 2025 Results Key Financial Results Revenue: US$2.65b (up 12% from 1Q 2024). Net income: US$220.0m (up 14% from 1Q 2024). Profit margin: 8.3% (up from 8.2% ...


Quest Diagnostics Inc (DGX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Consolidated Revenue: $2.65 billion, up 12.1% year-over-year. Organic Revenue Growth: 2.4% increase. Diagnostic Information Services Revenue: Up 12.7% compared to the prior year. Total Volume Growth: ...

Q1 2025 Quest Diagnostics Inc Earnings Call
Participants Shawn Bevec; Vice President - Investor Relations; Quest Diagnostics Inc James Davis; Executive Chairman of the Board, President, Chief Executive Officer; Quest Diagnostics Inc Sam Sama...

'Safe Haven' Stock Quest Diagnostics Bounds Off 50-Day Line On Its Solid Report
Quest Diagnostics stock remains a "safe haven," an analyst said Tuesday after the company topped first-quarter expectations. Continue Reading View Comments
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.